UA109966C2 - METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma - Google Patents
METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthmaInfo
- Publication number
- UA109966C2 UA109966C2 UAA201404493A UAA201404493A UA109966C2 UA 109966 C2 UA109966 C2 UA 109966C2 UA A201404493 A UAA201404493 A UA A201404493A UA A201404493 A UAA201404493 A UA A201404493A UA 109966 C2 UA109966 C2 UA 109966C2
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- treatment
- heart disease
- ischemic heart
- bronchial asthma
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 3
- 208000030603 inherited susceptibility to asthma Diseases 0.000 title abstract 2
- 208000031225 myocardial ischemia Diseases 0.000 title abstract 2
- 206010019233 Headaches Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 229940031651 nicorandil 20 mg Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід належить до медицини, а саме кардіології і пульмонології, і може бути використаний для лікуванні латентної ішемічної хвороби серця (ІХС) у хворих на бронхіальну астму (БА). Згідно з винаходом, на тлі базисної терапії бронхіальної астми додатково призначають з першої доби Нікорандил 20 мг двічі на добу зранку та ввечері, при виникненні головного болю дозу зменшують до 10 мг двічі на добу зранку та увечері, курсом 14 днів.The invention relates to medicine, namely cardiology and pulmonology, and can be used for the treatment of latent ischemic heart disease (CHD) in patients with bronchial asthma (AD). In accordance with the invention, against the background of baseline therapy for asthma, additionally prescribed from the first day Nicorandil 20 mg twice a day in the morning and evening, in the event of headache, reduce the dose to 10 mg twice a day in the morning and evening, 14 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201404493A UA109966C2 (en) | 2014-04-28 | 2014-04-28 | METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201404493A UA109966C2 (en) | 2014-04-28 | 2014-04-28 | METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA109966C2 true UA109966C2 (en) | 2015-10-26 |
Family
ID=54773587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201404493A UA109966C2 (en) | 2014-04-28 | 2014-04-28 | METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA109966C2 (en) |
-
2014
- 2014-04-28 UA UAA201404493A patent/UA109966C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (en) | NEW METHODS. | |
| BR112016028964A2 (en) | pd-1 and pd-11 antagonist treatment methods in combination with radiation therapy | |
| MX384234B (en) | USE OF PRIDOPIDINE FOR THE TREATMENT OF HUNTINGTON'S DISEASE. | |
| JOP20200031A1 (en) | Methods for treating osteoarthritis with transdermal CBD gel | |
| MX2022011334A (en) | Treatment of fabry disease in ert-naãve and ert-experienced patients. | |
| MX2017000628A (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia. | |
| EA201591679A1 (en) | METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE | |
| MX383254B (en) | COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101. | |
| MX377438B (en) | ADMINISTRATION OF TASIMELTEON UNDER FASTING CONDITIONS. | |
| EA202091112A1 (en) | SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION | |
| EA201691656A2 (en) | THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS | |
| MA39447A1 (en) | (s) -pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| EA201691299A1 (en) | APPLICATION OF LACHINIMODA TO SLOW DOWN THE PROGRESSION OF HANTINGTON'S DISEASE | |
| MA39448A1 (en) | (R) -pirlindole and its pharmaceutically acceptable salts for medical use | |
| EA201891008A2 (en) | TREATMENT OF SYMPTOMS ASSOCIATED WITH ANDROGEN-DEPRIVATION THERAPY | |
| UA109966C2 (en) | METHOD OF TREATMENT OF LATENT ISCHEMIC HEART DISEASE IN PATIENTS WITH Bronchial asthma | |
| PH12016502284A1 (en) | Cough medicine containing ambroxol hydrochloride | |
| EA201491048A1 (en) | CONNECTIONS OF TWO-CELLULAR RNA TO CASP2 AND THEIR APPLICATION | |
| EA202090416A1 (en) | METHODS FOR TREATING GASTROPARESIS SYMPTOMS USING A VELUSETRAGA | |
| MX385725B (en) | PHARMACEUTICAL COMPOSITION INCLUDING SUMATRIPTAN FOR THE TREATMENT OF MIGRAINE. | |
| EA202090452A1 (en) | COMPOUNDS FOR TREATMENT OF DISEASE VON HIPPEL-LINDAU | |
| UA104733U (en) | A method of treating gastropathy in patients with chronic obstructive pulmonary disease | |
| EA201692163A1 (en) | MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS | |
| EA201892739A1 (en) | METHODS OF TREATMENT OF ALZHEIMER'S DISEASE | |
| EA201800356A2 (en) | DRUG IN COMPLEX THERAPY FOR CHRONIC CYSTITIS AND METHOD OF COMPLEX THERAPY FOR CHRONIC CYSTITIS |